The role of anabolic hormones for wound healing in catabolic states

Robert H Demling, Robert H Demling

Abstract

Objective: The purpose of this paper is to present an overview of the interrelationship between hormones, nutrition, and wound healing.

Methods: The data on various hormones and their effects on specific elements of nutrition and wound healing are reviewed.

Results: The key anabolic hormones are human growth hormone, insulin-like growth factor-1, insulin, and testosterone and its analogs. Although each has specific metabolic actions, there is also a very important hormone-hormone interaction. A deficiency of these hormones occurs in acute and chronic catabolic states, resulting in lean mass loss and impairing the healing process.

Conclusion: There is a well-recognized interrelationship between hormones, nutrition, and wound healing. The anabolic process of protein synthesis, with new tissue formation, requires the action of anabolic hormones. Exogenous administration of these agents has been shown to maintain or increase lean body mass as well as directly stimulate the healing process through their anabolic and anticatabolic actions.

References

    1. Saito H. Anabolic agents in trauma and sepsis reflecting body mass and function. Nutrition. 1998;17:554–556.
    1. Biols G, Toigo G, Ciocechi B. Metabolic response to injury and sepsis: changes in protein metabolism. Nutrition. 1997;13:52–57.
    1. Wray C, Mammen J, Hasselgren P. Catabolic response to stress and potential benefits of nutrition support. Nutrition. 2002;18:97.
    1. Ziegler T, Wilmore D. Strategies for attenuating protein-catabolic responses in the critically ill. Am Rev Med. 1994;45:459.
    1. Bessey PQ, Jiang ZM, Johnson DJ, Smith RJ, Wilmore DW. Posttraumatic skeletal muscle proteolysis: the role of the hormonal environment. World J Surg. 1989;13:465–470.
    1. Streat S. Aggressive nutritional support does not prevent protein loss despite fat gain in septic intensive care patients. J Trauma. 1987;27:262–266.
    1. Wernerman J, Brandt R, Strandell T. The effect of stress hormones on the interorgan flux of amino acids and concentration of free amino acids in skeletal muscle. Clin Nutr. 1985;4:207–216.
    1. Cahill G. Starvation in men. N Engl J Med. 1970;282:668–675.
    1. Wolfe P, Hamill R, McDonald J. Transient hypogonadism caused by critical illness. J Clin Endoc Metab. 1985;60:494–500.
    1. Wallace J, Schwartz R. Involuntary weight loss in older outpatients: incidences and clinical significance. J Am Geriatr Soc. 1995;43:329–337.
    1. Kimball MJ, Williams-Burgess C. Failure to thrive: the silent epidemic of the elderly. Arch Psych Nurs. 1995;9:99–105.
    1. Jeveendra M, Ramos J, Shamos R, Shiller R. Decreased growth hormone levels in the catabolic phase of severe injury. Surgery. 1992;111:495–502.
    1. Kotler D. Magnitude of cell body mass depletion and timing of death from wasting in AIDS. Am J Clin Nutr. 1984;50:444–447.
    1. Roubenoff R, Kehajias J. The meaning and measurement of lean body mass. Nutr Rev. 1991;49:163–175.
    1. Torun B, Cherv F. Modern Nutrition in Health and Disease. Philadelphia: Lea and Felugan; 1994. Protein-energy malnutrition; p. 950.
    1. Forbes GB. The effect of anabolic steroids on lean body mass: the dose response curve. Metabolism. 1985;34:571–573.
    1. Demling R, Orgill D. The anticatabolic and wound healing effects of the testosterone analog, oxandrolone, after severe burn injury. J Crit Care Med. 2000;15:12–18.
    1. Woerman H, Strack R, de Boer H. Growth hormone secretion and administration in catabolic patients with emphasis on the critically ill patient. Neth J Med. 1992;41:222–244.
    1. Fleming R, Rutan R, Jahoor F. Effect of recombinant human growth hormone in catabolic hormones and free fatty acids following thermal injury. J Trauma. 1992;698:703–707.
    1. Hadley JS, Hinds CJ. Anabolic strategies in critical illness. Curr Opin Pharmacol. 2002;2:700–707.
    1. Demling R, DeSanti L. The anabolic steroid oxandrolone reverses the wound healing impairment in corticosteroid-dependent burn and wound patients. Wounds. 2001;13:203–208.
    1. Hansen T. Pharmacokinetics and acute lipolytic actions of growth hormone. Impact of age, body compensation, binding proteins and other hormones. Growth Horm IGF Res. 2002;12:372–378.
    1. Vahl N, Moller N, Lauretzen T. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex and body composition. J Clin Endocrinol Metab. 1997;82:3612–3618.
    1. Hansen T, Granholt C, Orskow H. Dose dependency of the pharmakinetics and acute lipolytic actions of growth hormone. J Clin Endocrinol Metab. 2002;87:4691–4698.
    1. Wolf S, Nicolai M, Dazemis G. Growth hormone treatment in catabolic states other than burns. Growth Horm IFG Res. 1998;8:117–119.
    1. Jackson N, Carroll P, Russell-Jones D. Effect of glutamine supplementation, GH and IGF-1 on glutamine metabolism in critically ill patients. Am J Physiol Endocrinol Metab. 2002;278:226–233.
    1. Suminski R, Robertson R, Goss F. Acute effect of amino acid ingestion and resistance exercise on plasma growth hormone concentration in young men. Int J Sport Nutr. 1997;7:48–60.
    1. Climmons D, Underwood L. Role of insulin-like growth factors and growth hormone in reversing catabolic states. Horm Res. 1992;38:37–40.
    1. Bondanelli M, Ambrosia M, Margutti A. Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head injury during recovery. Metabolism. 2002;51:1363–1369.
    1. Lang C, Frost R. Role of growth hormone, insulin-like growth factor-1 and insulin-like growth factor binding proteins in the catabolic response to injury and infection. Curr Opin Clin Nutr Metab Care. 2002;5:271–279.
    1. Coerper S, Wolf S, von Kiparski S, et al. Insulin-like growth factor accelerates gastric ulcer healings by stimulating cell proliferation and by inhibiting gastric acid secretion. Scand J Gastroenterol. 2001;36:921–992.
    1. Lin E, Goncalves JA, Lowry SF. Efficacy of nutritional pharmacology in surgical patients. Curr Opin Clin Nutr Metab Care. 1998;1:41–50.
    1. Betar M. Insulin-like growth factor-1 reverses diabetes-induced wound healing impairment in rats. Horm Metab Res. 1997;29:383–386.
    1. Ross R, Bentham J, Coakley J. The role of insulin, growth hormone and IGF-1 as anabolic agents in the critically ill. Intensive Care Med. 1993;19:54–57.
    1. Mulligan K, Tai V, Schambelan M. Use of growth hormone and other anabolic agents in AIDS wasting. JPEN J Parenter Enteral Nutr. 1999;23:S202–S209.
    1. Raschke M, Kolbeck S, Bail H. Homologous growth hormone accelerates healing of segmental bone defects. Bone. 2001;4:368–373.
    1. Lal S, Wolf S, Herndon D. Growth hormone, burns and tissue healing. Growth Horm IGF Res. 2002;10:39–43.
    1. Ghofrani A, Holler D, Shulmann K. The influence of systemic growth hormone administration on the healing time of skin graft donor sites in a pig model. Plast Reconstr Surg. 1999;104:470–475.
    1. Pierre E, Perez-Polo J, Mitchell A. Insulin-like growth factor-1 liposomal gene transfer and systemic growth hormone stimulate wound healing. J Burn Care Rehabil. 1997;4:287–289.
    1. Biolo G, Fleming R, Wolfe R. Physiological hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J Clin Invest. 1995;95:811–817.
    1. Zhang X, Chinkes D, Irtun O, Wolfe R. Anabolic action of insulin on skin wound protein is augmented by exogenesis amino acids. Am J Physiol Endocrinol Metab. 2002;282:308–315.
    1. Ruokonen E, Takala J. Dangers of growth hormone therapy in critically ill patients. Curr Opin Clin Nutr Care. 2002;5:199–209.
    1. Carroll P, Van den Berghe C. Safety aspects of pharmacological GH therapy in adults. Growth Horm IGF Res. 2001;11:166–172.
    1. Gore D. Insulin-like growth factor-1 in hypercatabolic states. Growth Horm IGF Res. 1998;8:107–109.
    1. Saito N. Anabolic agents in trauma and sepsis: repleting body mass and function. Nutrition. 1998;6:554–556.
    1. Inaba T. Effects of growth hormone and insulin-like growth factor-1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats. JPEN J Parenter Enteral Nutr. 1996;20:325–331.
    1. Boulivare S, Tamborlane D, Matthews L. Diverse effects of insulin-like growth factor-1 on glucose, lipid and amino acid metabolism. Am J Physiol. 1992;262:130–133.
    1. Dahn M, Lange M, Jacobs L. Insulin-like growth factor production is inhibited in human sepsis. Arch Surg. 1988;123:1409–1414.
    1. Strock L, Singh H, Abdullah A. The effect of insulin-like growth factor on post burn hypermetabolism. Surgery. 1990;108:161–164.
    1. Kupfer S, Underwood L, Baxter R. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor-1 by use of both agents simultaneously. J Clin Invest. 1993;91:391–393.
    1. Guler H, Zapf J, Froesch E. Short-term metabolic effects of recombinant human insulin-like growth factor-1 in healthy adults. N Engl J Med. 1987;317:137–140.
    1. Wicke C, Wagner S, Trabold O, et al. Age dependency of insulin-like growth factors, insulin-like growth factor-binding proteins and acid labile subunit in plasma and wounds of surgical patients. Wound Repair Regen. 2002;12:360–365.
    1. Liu Z, Barrett E. Human protein metabolism: its measurement and regulation. Am J Physiol Endocrinol Metab. 2002;283:E1105–E1112.
    1. Hatton J, Rapp R, Kudsk K. Intravenous insulin-like growth factor-1 in moderate to severe head injury: a phase II safety and efficacy trial. Neurosurg Focus. 1997;2:1–17.
    1. Lieberman S, Bukar J, Chen S. Effects of recombinant human insulin-like growth in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 1994;78:404–410.
    1. Blumenfield I, Saiiyi S, Lanir Y. Enhancement of bone defect healing in old rats by TGF beta and IGF-1. Exp Gerontol. 2002;37:53–55.
    1. Stanford A, Barbieri T, Van Loan M. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss. A randomized placebo controlled trial. JAMA. 1999;281:1282–1290.
    1. Davis T, Fiorotto M, Burrin D. Stimulation of protein synthesis by both insulin and amino acids is unique to skeletal muscle in neonatal pigs. Am J Physiol Endocrinol Metab. 2002;282:880–890.
    1. Volpi E, Mittendorfer B, Rasmussen B, Wolfe R. The response of muscle protein anabolism to combined hyperaminoacidemia and glucose-induced hyperinsulinemia is impaired in the elderly. J Clin Endocrinol Metab. 2000;85:4481–4490.
    1. Hadley J, Hinds C. Anabolic strategies in critical illness. Curr Opin Pharmacol. 2002;2:720–727.
    1. Zhang XJ, Chinkes DL, Wolfe SE, Wolfe RR. Insulin but not growth hormone stimulates protein anabolism in skin wound and muscle. Am J Physiol. 1999;276:E712–E720.
    1. Sakurai Y, Aarsland A, Herndon D. Stimulation of muscle protein synthesis by long-term insulin infusion in severely burned patients. Ann Surg. 1995;222:283–287.
    1. Ferrando A, Chinkes D, Wolf S. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999;229:148.
    1. Tennenbaum R, Shkear G. Effect of the anabolic steroid oxandrolone on wound healing. Oral Surg. 1970;30:834–835.
    1. Pierre E, Barrow R, Hawkins H. Effect of insulin on wound healing. J Trauma. 1999;44:342–345.
    1. Phillips T, Demircay Z, Sahu M. Hormonal effects on skin aging. Clin Geriatr Med. 2001;17:661–672.
    1. Zhang XJ, Chinkes DL, Irtun O, Wolfe RR. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. Am J Physiol Endocrinol Metab. 2002;282:E1308–E1315.
    1. Madibally S, Solomon V, Mitchell R. Influence of insulin therapy on burn wound healing in rats. J Surg Res. 2003;1099:92–100.
    1. Weringer E, Kelso J, Tamai I, Arquilla E. Effects of insulin on wound healing in diabetic mice. Acta Endocrinol. 1982;99:101–108.
    1. Christiana J, Frishman W. Testosterone and other anabolic steroids as cardiovascular drugs. Am J Ther. 1990;6:167–174.
    1. Matsumoto A. Andropause: clinical implications of the decline in serum testosterone levels with aging in man. J Gerontol Biol Sci Med Sci. 2002;57:76–99.
    1. Fox M, Minot A. Oxandrolone, a potent anabolic steroid. J Clin Endocrinol. 1962;22:921.
    1. Sheffield M, Wolfe R. The effect of short-term oxandrolone treatment on peripheral amino acid metabolism. J Burn Care Rehabil. 1999;2:127.
    1. Janssens H, Vanderscheuren D. Endocrinological aspects of aging in man: is hormone replacement of benefit? Eur J Obstet Gynecol Reprod Biol. 2000;92:9–12.
    1. Karim A, Ranney E, Zagarella BA. Oxandrolone disposition and metabolism in man. Clin Pharmacol Ther. 1973;14:862–866.
    1. Carson-Jurica MA, Schrader WT, O'Malley BW. Steroid receptor family: structure and functions. Endocrin Rev. 1990;11:201–220.
    1. Kuhn C. Anabolic steroids. Recent Prog Horm Res. 2002;57:411–434.
    1. Lafferty F, Spencer G, Pearson O. Effect of androgens, estrogens and high calcium intakes on bone formation and resorption in osteoporosis. Am J Med. 1969;36:514–528.
    1. Demling RH. Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair Regen. 2000;8:97–102.
    1. Demling RH, Orgill DP. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care. 2000;15:12–17.
    1. Achmud C. Insulin-like growth factors. Cell Biol Int. 1995;19:445–457.
    1. Demling RH, DeSanti L. Involuntary weight loss and the nonhealing wound: the role of anabolic agents. Adv Wound Care. 1999;12:1–14.
    1. Demling RH. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns. 1999;25:215–221.
    1. Schols A, Slangen J, Voloiris L, Wauter E. Weight loss is a reversible factor in the prognosis of chronic obstruction pulmonary disease. Am Rev Resp Dis. 1998;157:1791–1797.
    1. Demling RH, DeSanti L. Closure of the “non-healing wound” corresponds with correction of weight loss using the anabolic agent oxandrolone. Ostomy Wound Manage. 1998;44:58–62.
    1. Beiner JM, Jokl P, Cholewicki J, Panjabi MM. The effect of anabolic steroids and corticosteroids on healing of muscle contusion injury. Am J Sports Med. 1999;27:2–9.
    1. Falanga V, Greenberg A, Zhou L. Stimulation of collagen synthesis by the anabolic steroid stanazol. J Invest Dermatol. 1998;11:1193–1197.
    1. Erlich P. The influence of the anabolic steroid oxandrolone upon the expression of procollagen types I and II MRNA in human fibroblasts cultured in collagen or plastic. Wounds. 2001;13:66–72.
    1. Sweeney E, Evans D. Hepatic legions in patients treated with synthetic anabolic steroids. J Clin Pathol. 1976;29:626–633.
    1. Thompson P, Cullinane E, Sady S. Contrasting effects of testosterone and slanozolol on serum lipoprotein levels. JAMA. 1989;261:1165–1168.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir